Last updated: February 15, 2022
Sponsor: Fadoi Foundation, Italy
Overall Status: Active - Recruiting
Phase
N/A
Condition
Fever
Treatment
N/AClinical Study ID
NCT05254522
FADOI.07.2018
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- • fever (temperature > 38.3° C) found in several occasions of a duration exceeding 3,unable to make a diagnosis after a period of 3 days of hospitalization or after 3out-patients visits in Internal Medicine Dept. or Infection Diseases Dept.
- signed informed consent
Exclusion
Exclusion Criteria:
- • immunocompromised patients
- patients in treatment with steroidi (prednisone > 0,5 mg/Kg/die per > 4 weeks),anti-TNF, ciclofosfamide, tacrolimus, everolimus, sirolimus, azatioprina,ciclosporina, micofenolato, metotrexate
- neutropenic patients with less than 500 neutrofili/µL
- HIV positive patients
- nocosomial fever.
Study Design
Total Participants: 100
Study Start date:
September 19, 2019
Estimated Completion Date:
December 31, 2022
Study Description
Connect with a study center
ASUI di Trieste
Trieste,
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.